Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer.

Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer. — المؤلف: Zhang, Yun-Kai — Cancer letters 20191104

المؤلف

Zhang, Yun-Kai

النشر

Cancer letters 20191104

الوصف

104-112 p.

الموضوعات

ATP Binding Cassette Transporter, Subfamily G, Member 2؛ Animals؛ Antineoplastic Agents؛ Antineoplastic Combined Chemotherapy Protocols؛ Binding Sites؛ Cell Line, Tumor؛ Colonic Neoplasms؛ Dose-Response Relationship, Drug